Juvenescence
Juvenescence is a venture capital and development company focused on developing therapies targeting aging, age-related disease and regeneration.
All edits
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Official Website
Official Website
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 16 Feb, 2023
Golden AI
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 29 Aug, 2022
Mikhail Ramushevich
Mikhail Ramushevich
Edits on 28 Jul, 2022
Golden AI
Edits made to:
Article
Article
Juvenescence has invested in LyGenesis, Souvien Therapeutics, BYOMass, BHB Therapeutics, AgeX Therapeutics, Napa Therapeutics, FoxBio, Insilico Medicine, GenerAIt Pharmaceuticals and Netrapharma.
Edits on 27 Jun, 2022
Andrey Duzenko
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 May, 2022
Katrina-Kay Pettitt
Edits on 18 Feb, 2022
Keeri Tramm
Edits made to:
Infobox (+2 properties)
Infobox
Instagram
Pinterest
Edits on 16 Dec, 2021
Wyckliffe Otieno
Edits made to:
Infobox (+6 properties)
Article
Article
Infobox
Is a
Facebook
Industry
Location
Website
Edits on 9 Jul, 2021
Aime Anne Nisay
Edits made to:
Infobox (+1/-1 properties)
Infobox
Company status
Active
Golden AI
Aime Anne Nisay
Edits on 14 Jun, 2021
Erin Scherfner
Edits made to:
Infobox (+3 properties)
Infobox
Website
Edits on 11 May, 2021
Golden AI
Edits on 16 Apr, 2021
Henry Ogolla
Edits made to:
Timeline (+1 events) (+55 characters)
Timeline
April 15, 2021
Juvenescence announces the launch of its first product.
Find more companies like Juvenescence
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.